Lived experiences of survival following cancer treatments

SABCS 2023: Highlights

Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients

Significant clinical benefits observed with revumenib monotherapy in relapsed/refractory KMT2Ar acute leukaemia

Ide-cell enhances health-related quality of life for refractory multiple myeloma

Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC

Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer

Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma

Beat AML master trial: A clinical trial for acute myeloid leukaemia

BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL

Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL

SABCS 2023: Latest breast cancer diagnostics guidelines